Grant R. Stenton

738 total citations
23 papers, 615 citations indexed

About

Grant R. Stenton is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Grant R. Stenton has authored 23 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Grant R. Stenton's work include Mast cells and histamine (13 papers), Asthma and respiratory diseases (8 papers) and Immune Cell Function and Interaction (5 papers). Grant R. Stenton is often cited by papers focused on Mast cells and histamine (13 papers), Asthma and respiratory diseases (8 papers) and Immune Cell Function and Interaction (5 papers). Grant R. Stenton collaborates with scholars based in Canada, United States and Hong Kong. Grant R. Stenton's co-authors include A. Dean Befus, Harissios Vliagoftis, Mark Gilchrist, Alan D. Schreiber, Osamu Nohara, Marina Ulanova, Shaheed Merani, Lakshmi Puttagunta, Curtis Harwig and Lloyd Mackenzie and has published in prestigious journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Grant R. Stenton

22 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant R. Stenton Canada 14 289 171 166 114 69 23 615
Daniel Brigger Switzerland 14 197 0.7× 197 1.2× 201 1.2× 160 1.4× 39 0.6× 17 723
Jeff Thompson United States 11 687 2.4× 213 1.2× 238 1.4× 261 2.3× 36 0.5× 15 1.1k
Taras Lyubchenko United States 13 289 1.0× 67 0.4× 137 0.8× 64 0.6× 28 0.4× 33 596
Evan Boetticher United States 17 302 1.0× 336 2.0× 437 2.6× 155 1.4× 28 0.4× 23 886
Yves T. Falanga United States 11 315 1.1× 166 1.0× 247 1.5× 90 0.8× 23 0.3× 15 570
KB Pryzwansky United States 14 258 0.9× 187 1.1× 287 1.7× 103 0.9× 44 0.6× 25 678
Ivana Hálová Czechia 13 367 1.3× 109 0.6× 168 1.0× 147 1.3× 32 0.5× 21 509
Giorgio Giannattasio Italy 12 254 0.9× 133 0.8× 211 1.3× 60 0.5× 43 0.6× 22 591
K. Merétey Hungary 9 235 0.8× 74 0.4× 121 0.7× 47 0.4× 33 0.5× 19 450
Sarah J. Collington United States 8 487 1.7× 272 1.6× 169 1.0× 158 1.4× 30 0.4× 8 673

Countries citing papers authored by Grant R. Stenton

Since Specialization
Citations

This map shows the geographic impact of Grant R. Stenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant R. Stenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant R. Stenton more than expected).

Fields of papers citing papers by Grant R. Stenton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant R. Stenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant R. Stenton. The network helps show where Grant R. Stenton may publish in the future.

Co-authorship network of co-authors of Grant R. Stenton

This figure shows the co-authorship network connecting the top 25 collaborators of Grant R. Stenton. A scholar is included among the top collaborators of Grant R. Stenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant R. Stenton. Grant R. Stenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stenton, Grant R., Curtis Harwig, Csaba Szabó, et al.. (2017). AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis. British Journal of Pharmacology. 174(18). 3045–3057. 15 indexed citations
2.
Leaker, Brian, Brian O’Connor, Peter J. Barnes, et al.. (2013). The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma. European Respiratory Journal. 42(Suppl 57). P1592–P1592. 1 indexed citations
3.
Stenton, Grant R., Lloyd Mackenzie, Patrick Tam, et al.. (2012). Characterization of AQX‐1125, a small‐molecule SHIP1 activator. British Journal of Pharmacology. 168(6). 1519–1529. 41 indexed citations
4.
5.
Ulanova, Marina, et al.. (2007). Involvement of Syk protein tyrosine kinase in LPS-induced responses in macrophages. Journal of Endotoxin Research. 13(2). 117–125. 26 indexed citations
6.
7.
Ulanova, Marina, Lakshmi Puttagunta, Grant R. Stenton, et al.. (2004). Frontline: Inhibition of allergen‐induced pulmonary inflammation by the tripeptide feG: a mimetic of a neuro‐endocrine pathway. European Journal of Immunology. 34(12). 3315–3325. 34 indexed citations
8.
Harris, Peter, et al.. (2004). IPL576,092, a novel anti-inflammatory compound, inhibits leukocyte infiltration and changes in lung function in response to allergen challenge. Pulmonary Pharmacology & Therapeutics. 17(5). 309–318. 10 indexed citations
9.
Stenton, Grant R., Marina Ulanova, Shaheed Merani, et al.. (2002). Inhibition of Allergic Inflammation in the Airways Using Aerosolized Antisense to Syk Kinase. The Journal of Immunology. 169(2). 1028–1036. 97 indexed citations
10.
Stenton, Grant R., Osamu Nohara, Harissios Vliagoftis, et al.. (2002). Proteinase-Activated Receptor (PAR)-1 and -2 Agonists Induce Mediator Release from Mast Cells by Pathways Distinct from PAR-1 and PAR-2. Journal of Pharmacology and Experimental Therapeutics. 302(2). 466–474. 56 indexed citations
11.
Lin, Tong‐Jun, Grant R. Stenton, Mark Gilchrist, et al.. (2000). Activation of Macrophage CD8: Pharmacological Studies of TNF and IL-1β Production. The Journal of Immunology. 164(4). 1783–1792. 30 indexed citations
12.
Stenton, Grant R., Osamu Nohara, Mark Gilchrist, et al.. (2000). Aerosolized Syk Antisense Suppresses Syk Expression, Mediator Release from Macrophages, and Pulmonary Inflammation. The Journal of Immunology. 164(7). 3790–3797. 62 indexed citations
13.
Lin, Tong‐Jun, Mark Gilchrist, Osamu Nohara, et al.. (1999). Novel CD8 Molecule on Macrophages and Mast Cells: Expression, Function and Signaling. International Archives of Allergy and Immunology. 118(2-4). 180–182. 16 indexed citations
14.
Nohara, Osamu, et al.. (1999). Reverse transcriptase in situ polymerase chain reaction for gene expression in rat mast cells and macrophages. Journal of Immunological Methods. 226(1-2). 147–158. 5 indexed citations
15.
Lin, Tong‐Jun, et al.. (1998). Mast Cells Express Novel CD8 Molecules That Selectively Modulate Mediator Secretion. The Journal of Immunology. 161(11). 6265–6272. 21 indexed citations
16.
Stenton, Grant R., Harissios Vliagoftis, & A. Dean Befus. (1998). Role of Intestinal Mast Cells in Modulating Gastrointestinal Pathophysiology. Annals of Allergy Asthma & Immunology. 81(1). 1–15. 75 indexed citations
17.
Lau, H. Y. A. & Grant R. Stenton. (1998). Effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 specific inhibitors on mediator release from rat peritoneal mast cells. Inflammation Research. 47(0). 22–23. 4 indexed citations
18.
Stenton, Grant R. & H. Y. A. Lau. (1997). Effects of histamine agonists and antagonists on rat peritoneal mast cells. Inflammation Research. 46(0). 15–16. 6 indexed citations
19.
Stenton, Grant R., Sharron Chow, & H. Y. A. Lau. (1997). INHIBITION OF RAT PERITONEAL MAST CELL EXOCYTOSIS BY FRUSEMIDE:. Life Sciences. 62(3). PL/49–PL/54. 5 indexed citations
20.
Stenton, Grant R. & H. Y. A. Lau. (1996). Inhibition of rat peritoneal mast cell exocytosis by frusemide: A study with different secretagogues. Inflammation Research. 45(10). 508–512. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Brigger Breakdown of academic impact, for papers by Jeff Thompson Breakdown of academic impact, for papers by Taras Lyubchenko Breakdown of academic impact, for papers by Evan Boetticher Breakdown of academic impact, for papers by Yves T. Falanga Breakdown of academic impact, for papers by KB Pryzwansky Breakdown of academic impact, for papers by Ivana Hálová Breakdown of academic impact, for papers by Giorgio Giannattasio Breakdown of academic impact, for papers by K. Merétey Breakdown of academic impact, for papers by Sarah J. Collington
Rankless by CCL
2026